These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Validation of functional liver imaging scores (FLIS) derived from gadoxetic acid-enhanced MRI in patients with chronic liver disease and liver cirrhosis: the relationship between Child-Pugh score and FLIS. Lee HJ, Hong SB, Lee NK, Kim S, Seo HI, Kim DU, Han SY, Choo KS. Eur Radiol; 2021 Nov; 31(11):8606-8614. PubMed ID: 33881570 [Abstract] [Full Text] [Related]
5. Prediction of Decompensation and Death in Advanced Chronic Liver Disease Using Deep Learning Analysis of Gadoxetic Acid-Enhanced MRI. Heo S, Lee SS, Kim SY, Lim YS, Park HJ, Yoon JS, Suk HI, Sung YS, Park B, Lee JS. Korean J Radiol; 2022 Dec; 23(12):1269-1280. PubMed ID: 36447415 [Abstract] [Full Text] [Related]
6. Comparison of the efficacy of the gadoxetic acid MRI-derived relative enhancement index (REI) and functional liver imaging score (FLIS) in predicting liver function: validation with Albumin-Bilirubin (ALBI) grade. Eryuruk U, Tasdemir MN, Karasu HI, Aslan S. Abdom Radiol (NY); 2024 May; 49(5):1456-1466. PubMed ID: 38653813 [Abstract] [Full Text] [Related]
7. The value of contrast-enhanced portal vein imaging at the hepatobiliary phase obtained with gadobenate dimeglumine for predicting decompensation and transplant-free survival in chronic liver disease. Cai S, Lin N, Yang Y, Ma W, Wang Y, Lin X, Wang X, Zhao X. Eur Radiol; 2023 May; 33(5):3425-3434. PubMed ID: 36897349 [Abstract] [Full Text] [Related]
10. Total Bilirubin Level as a Predictor of Suboptimal Image Quality of the Hepatobiliary Phase of Gadoxetic Acid-Enhanced MRI in Patients with Extrahepatic Bile Duct Cancer. Hwang JA, Min JH, Kim SH, Choi SY, Lee JE, Moon JY. Korean J Radiol; 2022 Apr; 23(4):389-401. PubMed ID: 35029076 [Abstract] [Full Text] [Related]
11. Dynamics in Liver Stiffness Measurements Predict Outcomes in Advanced Chronic Liver Disease. Semmler G, Yang Z, Fritz L, Köck F, Hofer BS, Balcar L, Hartl L, Jachs M, Stopfer K, Schedlbauer A, Neumayer D, Maurer J, Müllner-Bucsics T, Simbrunner B, Scheiner B, Trauner M, Mandorfer M, Reiberger T, Bauer DJM. Gastroenterology; 2023 Oct; 165(4):1041-1052. PubMed ID: 37442301 [Abstract] [Full Text] [Related]
12. Inter-reader reliability of functional liver imaging score derived from gadoxetic acid-enhanced MRI: a meta-analysis. Kim NH, Kang JH. Abdom Radiol (NY); 2023 Mar; 48(3):886-894. PubMed ID: 36576517 [Abstract] [Full Text] [Related]
13. Evaluation of liver function in patients with liver cirrhosis and chronic liver disease using functional liver imaging scores at different acquisition time points. Tang G, Liu J, Liu P, Huang F, Shao X, Chen Y, Xie A. Front Genet; 2022 Mar; 13():1071025. PubMed ID: 36561314 [Abstract] [Full Text] [Related]
15. Effect of type 2 diabetes on liver images of GD-EOB-DTPA-enhanced MRI during the hepatobiliary phase. Zhang WY, Sun HY, Zhang WL, Feng R. Sci Rep; 2023 Jan 11; 13(1):543. PubMed ID: 36631556 [Abstract] [Full Text] [Related]